Volume of malignant melanoma is superior to thickness as a prognostic indicator. Preliminary observation - PubMed (original) (raw)
Affiliations
- PMID: 1934639
Volume of malignant melanoma is superior to thickness as a prognostic indicator. Preliminary observation
R J Friedman et al. Dermatol Clin. 1991 Oct.
Abstract
There are many clinical and histologic factors that are known to be valuable in predicting survival rates for patients with cutaneous malignant melanomas. Breslow thickness is considered to be the most reliable prognostic factor; however, thickness is a unidimensional measurement. A more accurate mensuration to predict biologic behavior might be one that takes into account the three-dimensional volume of the neoplasm. In a study of 35 primary malignant melanomas, the volumes of the dermal components of the tumors were calculated. Those patients with tumor volumes of 200 mm3 or less had a 91.4% 5-year disease-free survival rate, compared with survival rate of only 16.7% for those patients whose lesions had tumor volumes exceeding 200 mm3. On multivariate analysis, tumor volume exceeded thickness as a prognostic indicator. Thus, measurement of tumor volume proved to be of greater significance than thickness in predicting the outcome for patients with malignant melanomas.
Similar articles
- Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS, Haddad F, Messina J, Cantor AB, Fitzmorris K, Reintgen DS, Fenske NA, Glass LF. Cherpelis BS, et al. J Am Acad Dermatol. 2001 May;44(5):762-6. doi: 10.1067/mjd.2001.112346. J Am Acad Dermatol. 2001. PMID: 11312421 - A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
McKenna DB, Lee RJ, Prescott RJ, Doherty VR. McKenna DB, et al. Br J Dermatol. 2004 Mar;150(3):523-30. doi: 10.1111/j.1365-2133.2004.05849.x. Br J Dermatol. 2004. PMID: 15030337 - Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.
Barnhill RL, Fine JA, Roush GC, Berwick M. Barnhill RL, et al. Cancer. 1996 Aug 1;78(3):427-32. doi: 10.1002/(SICI)1097-0142(19960801)78:3<427::AID-CNCR8>3.0.CO;2-G. Cancer. 1996. PMID: 8697387 - Primary cutaneous malignant melanoma.
Maize JC. Maize JC. J Am Acad Dermatol. 1983 Jun;8(6):857-63. doi: 10.1016/s0190-9622(83)80017-6. J Am Acad Dermatol. 1983. PMID: 6345610 Review. - [Extracutaneous malignant melanomas: clinical aspects and biology].
Peter RU, Landthaler M, Braun-Falco O. Peter RU, et al. Hautarzt. 1992 Sep;43(9):535-41. Hautarzt. 1992. PMID: 1399597 Review. German.
Cited by
- Comparison of the prognostic value of microscopically measured invasive width versus macroscopic width in cutaneous melanoma shows the superiority of microscopic invasive width measurement.
Bamford M, Udensi L, Khanna A, O'Riordan M, Saldanha G. Bamford M, et al. J Cutan Pathol. 2022 Jun;49(6):536-542. doi: 10.1111/cup.14220. Epub 2022 Mar 21. J Cutan Pathol. 2022. PMID: 35262956 Free PMC article. - Prognostic significance of tumor size for primary invasive cutaneous melanoma: A population-based study, 2004-2016.
Ma Q, Suo H, Zhu L, Qian Y, Sun X, Xie J, Li Q, Fu Y, Li J, Tao J. Ma Q, et al. Cancer Med. 2020 Jul;9(13):4561-4571. doi: 10.1002/cam4.3065. Epub 2020 May 5. Cancer Med. 2020. PMID: 32367684 Free PMC article. - Correlation between initial tumour volume and treatment duration on Dabrafenib: observation study of subjects with BRAF mutant melanoma on the BRF112680 trial.
Ali A, Dumbrava M, Riddell K, Stewart N, Ward R, Ibrahim AK, Chin M. Ali A, et al. BMC Cancer. 2020 Apr 22;20(1):342. doi: 10.1186/s12885-020-06848-8. BMC Cancer. 2020. PMID: 32321474 Free PMC article. Clinical Trial. - Breslow Density Is a Novel Prognostic Feature That Adds Value to Melanoma Staging.
Saldanha G, Yarrow J, Pancholi J, Flatman K, Teo KW, Elsheik S, Harrison R, O'Riordan M, Bamford M. Saldanha G, et al. Am J Surg Pathol. 2018 Jun;42(6):715-725. doi: 10.1097/PAS.0000000000001034. Am J Surg Pathol. 2018. PMID: 29462090 Free PMC article. - Computer-assisted measurement of primary tumor area is prognostic of recurrence-free survival in stage IB melanoma patients.
Rosenbaum BE, Schafer CN, Han SW, Osman I, Zhong H, Brinster N. Rosenbaum BE, et al. Mod Pathol. 2017 Oct;30(10):1402-1410. doi: 10.1038/modpathol.2017.64. Epub 2017 Jul 21. Mod Pathol. 2017. PMID: 28731044 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical